Ads
related to: investing- Merrill Advisor Match
With Merrill Advisor Match, We've
Made It Easier To Find An Advisor.
- Work With Merrill
Plan, Preserve And Help Fulfill
Your Vision Of The Future.
- Preparing For Retirement
What Can You Do Now to Accomplish
Your Retirement Goals Later?
- Our Products & Solutions
Products And Services You Need
To Pursue Your Financial Goals.
- Merrill Advisor Match
Search results
Turtle Beach director sells over $83k in company stock By Investing.com
Investing.com· 1 hour agoIn a recent transaction, Lloyd Gregory Ballard (TSX:BLDP), a director of Turtle Beach Corp...
Sypris Solutions director Convis buys $148 worth of shares By Investing.com
Investing.com· 1 hour agoGary L. Convis, a director at Sypris (NASDAQ:SYPR) Solutions Inc. (NASDAQ:SYPR), has recently...
Gap CFO Katrina O'Connell sells shares worth over $580k By Investing.com
Investing.com· 2 hours agoGap Inc's (NYSE:GPS) Chief Financial Officer, Katrina O'Connell, has recently engaged in significant...
June Kicks Off With Concerning Market Signals Brewing Under the Surface | Investing.com PH
Investing.com· 16 hours agoShares Analysis by Investing.com (Calogero Selvaggio) covering: S&P 500. Read Investing.com...
Nuvei expands Visa Direct in Colombia By Investing.com
Investing.com· 5 hours agoNuvei (TSX:NVEI) Corporation (NASDAQ:NVEI) (TSX:NVEI), a Canadian fintech firm, has announced a...
Citi sets Sensei Biotherapeutics stock to buy with $4 target By Investing.com
Investing.com· 4 hours agoOn Monday, Citi resumed coverage of Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating, and a...
GFL Environmental shares surge on buyout interest By Investing.com
Investing.com· 5 hours agoOn Monday, GFL Environmental Inc. (NYSE:GFL) shares experienced a notable increase, climbing 10% in...
Leggett & Platt CEO buys $273k in company stock By Investing.com
Investing.com· 5 hours agoIn a recent transaction, Karl G. Glassman, the President and CEO of Leggett & Platt Inc. (NYSE:LEG),...
DexCom maintains $150 target amid new FDA approval By Investing.com
Investing.com· 5 hours agoOn Monday, Oppenheimer maintained its Outperform rating and $150.00 price target for DexCom...
Bitcoin’s Last Hurdle Before It Can Rally to $90K? | Investing.com
Investing.com· 4 hours agoIn that case, Bitcoin can attack the upper descending grey trend line of the potential Bull-flag...
Ad
related to: investing